Unilever's U.S. Growth Slows As Wellness Brands Normalize -- Market Talk
Dow Jones
Feb 16
1201 GMT - Unilever's wellness brands Liquid IV and Nutrafol have had exceptional growth in the past but that is normalizing now, which means its overall U.S. growth will slow, analysts at HSBC say. Although the consumer brands giant anticipates improvement in its fourth quarter, there might be persistent competition in the area, they write. "This could deprive Unilever of an important component of its outperformance versus end markets," they add. Meanwhile, there are hopes for emerging market acceleration in 2026, they add. Shares are down 0.1% at 54.27 pounds. (aimee.look@wsj.com)
(END) Dow Jones Newswires
February 16, 2026 07:01 ET (12:01 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.